{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T03:00:39Z","timestamp":1780542039952,"version":"3.54.1"},"reference-count":169,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009465","name":"Corporaci\u00f3n de Fomento de la Producci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009465","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Neurosci."],"abstract":"<jats:p>Alzheimer\u2019s disease (AD) is a multifactorial neurodegenerative disease, the primary cause of dementia in people over 65 years old. AD is characterized by two molecular hallmarks, the intracellular neurofibrillary tangles of tau and amyloid beta oligomers, which are aggregates of hyperphosphorylated tau and amyloid beta peptides, respectively. These hallmarks gave rise to the two main theories that have opened the way for available treatments, such as FDA-approved memantine, and A\u03b2 (aducanumab, lecanemab) and tau immunotherapies. Tau immunotherapy, especially multitarget approaches, has been recently proven effective. However, drugs against amyloid plaques had a non-successful outcome, despite their contributions to AD knowledge. An innovative approach comes from the multitarget concept, based on bioactive molecules and nutraceuticals. Interestingly, the use of early detection biomarkers such as Alz-Tau<jats:sup>\u00ae<\/jats:sup>, SIMOA<jats:sup>\u00ae<\/jats:sup>, and the recent Lumipulse\u2122 test, are an important support to orient AD therapies based on the modifications of the styles of life. This includes physical exercise, a healthy diet, mindfulness, and cognitive stimulation, among others. All of the above analyses are critical to switch the focus to the prevention of AD.<\/jats:p>","DOI":"10.3389\/fncel.2025.1655342","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:45:11Z","timestamp":1757573111000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Alzheimer\u2019s disease: where do we stand now and what are the strategic interventions?"],"prefix":"10.3389","volume":"19","author":[{"given":"Andrea","family":"Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Geywitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo B.","family":"Maccioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/biof.2039","article-title":"Antioxidant, anti-inflammatory and epigenetic potential of curcumin in Alzheimer\u2019s disease.","volume":"50","author":"Abdul-Rahman","year":"2024","journal-title":"Biofactors"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.4103\/1673-5374.386406","article-title":"Amyloid-beta and tau protein beyond Alzheimer\u2019s disease.","volume":"19","author":"Abyadeh","year":"2024","journal-title":"Neural Regen. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.3390\/molecules24234255","article-title":"Anthocyanins potentially contribute to defense against Alzheimer\u2019s disease.","volume":"24","author":"Afzal","year":"2019","journal-title":"Molecules"},{"key":"B4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.9781\/ijimai.2021.04.005","article-title":"Alzheimer disease detection techniques and methods: A review.","volume":"6","author":"Afzal","year":"2021","journal-title":"Int. J. Interact. Multimedia Artif. Intell."},{"key":"B5","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/hipo.22405","article-title":"Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer\u2019s disease and neuronal loss.","volume":"25","author":"Ager","year":"2015","journal-title":"Hippocampus"},{"key":"B6","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/agm2.12216","article-title":"A consolidated review on stem cell therapy for treatment and management of Alzheimer\u2019s disease.","volume":"5","author":"Ahmad","year":"2022","journal-title":"Aging Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"102229","DOI":"10.1016\/j.arr.2024.102229","article-title":"Evolving therapeutic interventions for the management and treatment of Alzheimer\u2019s disease.","volume":"95","author":"Ahmad","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1002\/alz.13809","article-title":"Alzheimer\u2019s disease facts and figures.","volume":"20","year":"2024","journal-title":"Alzheimers Dement."},{"key":"B9","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3390\/ph16070960","article-title":"Scaling the Andean Shilajit: A novel neuroprotective agent for Alzheimer\u2019s disease.","volume":"16","author":"Andrade","year":"2023","journal-title":"Pharmaceuticals"},{"key":"B10","doi-asserted-by":"publisher","first-page":"6412","DOI":"10.1038\/s41598-018-24501-0","article-title":"Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-\u03b2.","volume":"8","author":"Arndt","year":"2018","journal-title":"Sci. Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1002\/alz.12841","article-title":"Plasma and CSF biomarkers in a memory clinic: Head-to-head comparison of phosphorylated tau immunoassays.","volume":"19","author":"Ashton","year":"","journal-title":"Alzheimers Dement."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1101\/2023.07.11.23292493","article-title":"Diagnostic accuracy of the plasma ALZpath pTau217 immunoassay to identify Alzheimer\u2019s disease pathology.","author":"Ashton","year":"","journal-title":"medRxiv"},{"key":"B13","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3233\/JAD-230040","article-title":"Playing Russian roulette with Alzheimer\u2019s disease patients: Do the cognitive benefits of lecanemab outweigh the risk of edema, stroke and encephalitis?","volume":"92","author":"Atwood","year":"2023","journal-title":"J. Alzheimers Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"eabb2639","DOI":"10.1126\/scitranslmed.abb2639","article-title":"Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer\u2019s disease.","volume":"13","author":"Ayalon","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e2512923","DOI":"10.1001\/jama.2025.12923","article-title":"Structured vs self-guided multidomain lifestyle interventions for global cognitive function: The US POINTER randomized clinical trial.","volume":"2025","author":"Baker","year":"2025","journal-title":"JAMA"},{"key":"B16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13195-020-00596-4","article-title":"Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer\u2019s disease and PET amyloid-positive patient identification.","volume":"12","author":"Barth\u00e9lemy","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s13195-021-00939-9","article-title":"Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231.","volume":"13","author":"Bayoumy","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1140975","DOI":"10.3389\/fnagi.2023.1140975","article-title":"Improved connectivity and cognition due to cognitive stimulation in Alzheimer\u2019s disease.","volume":"15","author":"Behfar","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.nrl.2019.06.002","article-title":"Oxidative stress, the immune response, synaptic plasticity, and cognition in transgenic models of Alzheimer disease.","volume":"37","author":"Bello-Medina","year":"2022","journal-title":"Neurologia"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.3390\/nu13113868","article-title":"Microbiota-derived \u03b2-amyloid-like peptides trigger Alzheimer\u2019s disease-related pathways in the SH-SY5Y neural cell line.","volume":"13","author":"Blanco-M\u00edguez","year":"2021","journal-title":"Nutrients"},{"key":"B21","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer\u2019s disease.","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1111\/j.1582-4934.2011.01318.x","article-title":"Possible implications of insulin resistance and glucose metabolism in Alzheimer\u2019s disease pathogenesis.","volume":"15","author":"Bosco","year":"2011","journal-title":"J. Cell Mol. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/alz.12301","article-title":"Plasma p-tau181, p-tau217, and other blood-based Alzheimer\u2019s disease biomarkers in a multi-ethnic, community study.","volume":"17","author":"Brickman","year":"2021","journal-title":"Alzheimers Dement."},{"key":"B24","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1159\/000007969","article-title":"Neurofibrillary tangles and Alzheimer\u2019s disease.","volume":"40","author":"Brion","year":"1998","journal-title":"Eur. Neurol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jalz.2007.04.381","article-title":"Forecasting the global burden of Alzheimer\u2019s disease.","volume":"3","author":"Brookmeyer","year":"2007","journal-title":"Alzheimers Dement."},{"key":"B26","doi-asserted-by":"publisher","first-page":"480890","DOI":"10.4061\/2011\/480890","article-title":"Cognitive stimulation for apathy in probable early-stage Alzheimer\u2019s.","volume":"2011","author":"Buettner","year":"2011","journal-title":"J. Aging Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1465871","DOI":"10.3389\/fnagi.2024.1465871","article-title":"Comparative the efficacy and safety of gosuranemab, semorinemab, tilavonemab, and zagotenemab in patients with Alzheimer\u2019s disease: A systematic review and network meta-analysis of randomized controlled trials.","volume":"16","author":"Cai","year":"2025","journal-title":"Front. Aging Neurosci."},{"key":"B28","volume-title":"The wisdom of the body.","author":"Cannon","year":"1932"},{"key":"B29","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.arcmed.2012.10.010","article-title":"Can nutraceuticals prevent Alzheimer\u2019s disease? Potential therapeutic role of a formulation containing shilajit and complex B vitamins.","volume":"43","author":"Carrasco-Gallardo","year":"","journal-title":"Arch. Med. Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"674142","DOI":"10.1155\/2012\/674142","article-title":"Shilajit: A natural phytocomplex with potential procognitive activity.","volume":"2012","author":"Carrasco-Gallardo","year":"","journal-title":"Int. J. Alzheimers Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3390\/nu14040819","article-title":"Phenolic acids and prevention of cognitive decline: Polyphenols with a neuroprotective role in cognitive disorders and Alzheimer\u2019s disease.","volume":"14","author":"Caruso","year":"2022","journal-title":"Nutrients"},{"key":"B32","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.1002\/hbm.24782","article-title":"Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer\u2019s disease and mild cognitive impairment.","volume":"40","author":"Chandra","year":"2019","journal-title":"Hum. Brain Mapp."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1136\/gutjnl-2021-326269","article-title":"Gut microbiota regulate Alzheimer\u2019s disease pathologies and cognitive disorders via PUFA-associated neuroinflammation.","volume":"71","author":"Chen","year":"2022","journal-title":"Gut"},{"key":"B34","doi-asserted-by":"publisher","first-page":"249","DOI":"10.14283\/jpad.2021.22","article-title":"Effects of folic acid and vitamin B12 supplementation on cognitive impairment and inflammation in patients with Alzheimer\u2019s disease: A randomized, single-blinded, placebo-controlled trial.","volume":"8","author":"Chen","year":"2021","journal-title":"J. Prev. Alzheimers Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e19313","DOI":"10.1097\/MD.0000000000019313","article-title":"Meditation treatment of Alzheimer disease and mild cognitive impairment: A protocol for systematic review.","volume":"99","author":"Chen","year":"2020","journal-title":"Medicine"},{"key":"B36","doi-asserted-by":"publisher","first-page":"6328","DOI":"10.3390\/ijms24076328","article-title":"The potential benefits of quercetin for brain health: A review of anti-inflammatory and neuroprotective mechanisms.","volume":"24","author":"Chiang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.brainresbull.2011.11.014","article-title":"Antioxidant properties of natural polyphenols and their therapeutic potentials for Alzheimer\u2019s disease.","volume":"87","author":"Choi","year":"2012","journal-title":"Brain Res. Bull."},{"key":"B38","doi-asserted-by":"publisher","first-page":"eaan8821","DOI":"10.1126\/science.aan8821","article-title":"Combined adult neurogenesis and BDNF mimic exercise effects on cognition in an Alzheimer\u2019s mouse model.","volume":"361","author":"Choi","year":"2018","journal-title":"Science"},{"key":"B39","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/jnc.14635","article-title":"Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer\u2019s and Parkinson\u2019s diseases.","volume":"151","author":"Cilento","year":"2019","journal-title":"J. Neurochem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3233\/JAD-2011-110623","article-title":"Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with Alzheimer\u2019s disease.","volume":"27","author":"Cornejo","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"251426","DOI":"10.1155\/2012\/251426","article-title":"Protein tau: Prime cause of synaptic and neuronal degeneration in Alzheimer\u2019s disease.","volume":"2012","author":"Crespo-Biel","year":"2012","journal-title":"Int. J. Alzheimers Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"972","DOI":"10.2174\/1567205017666201130092427","article-title":"The association between TNF-alpha, IL-1 alpha and IL-10 with Alzheimer\u2019s Disease.","volume":"17","author":"Culjak","year":"2020","journal-title":"Curr. Alzheimer Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3233\/JAD-180184","article-title":"Improvement of main cognitive functions in patients with Alzheimer\u2019s disease after treatment with coconut oil enriched mediterranean diet: A pilot study.","volume":"65","author":"de la Rubia Ort\u00ed","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1080\/01616412.1993.11740127","article-title":"Can disturbed brain microcirculation cause Alzheimer\u2019s disease?","volume":"15","author":"de la Torre","year":"1993","journal-title":"Neurol. Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1365-2990.1990.tb01158.x","article-title":"Human herpes virus infections and Alzheimer\u2019s disease.","volume":"16","author":"Deatly","year":"1990","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s42003-024-05860-z","article-title":"Ketogenic diet and BHB rescue the fall of long-term potentiation in an Alzheimer\u2019s mouse model and stimulates synaptic plasticity pathway enzymes.","volume":"7","author":"Di Lucente","year":"2024","journal-title":"Commun. Biol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1750-1326-5-15","article-title":"Soluble amyloid-beta, effect on cerebral arteriolar regulation and vascular cells.","volume":"5","author":"Dietrich","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"B48","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.1002\/alz.13007","article-title":"Effects of a ketogenic and low-fat diet on the human metabolome, microbiome, and foodome in adults at risk for Alzheimer\u2019s disease.","volume":"19","author":"Dilmore","year":"2023","journal-title":"Alzheimers Dement."},{"key":"B49","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3390\/nu16030412","article-title":"The role of diet and gut microbiota in Alzheimer\u2019s disease.","volume":"16","author":"Dissanayaka","year":"2024","journal-title":"Nutrients"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1017\/S1041610214001033","article-title":"Stress and dementia.","volume":"26","author":"Doyle","year":"2014","journal-title":"Int. Psychogeriatr."},{"key":"B51","doi-asserted-by":"publisher","first-page":"728993","DOI":"10.3389\/fnhum.2021.728993","article-title":"Effects of meditation on structural changes of the brain in patients with mild cognitive impairment or Alzheimer\u2019s disease dementia.","volume":"15","author":"Dwivedi","year":"2021","journal-title":"Front. Hum. Neurosci."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1101\/2023.05.23.23290253","article-title":"Causal evidence that herpes zoster vaccination prevents a proportion of dementia cases.","author":"Eyting","year":"2023","journal-title":"medRxiv"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e208061","DOI":"10.1212\/WNL.0000000000208061","article-title":"Assessment of efficacy and safety of zagotenemab: Results from PERISCOPE-ALZ, a phase 2 study in early symptomatic Alzheimer disease.","volume":"102","author":"Fleisher","year":"2024","journal-title":"Neurology"},{"key":"B54","first-page":"69","article-title":"El Estr\u00e9s cr\u00f3nico, \u00bffactor de riesgo para la enfermedad de alzheimer?","volume":"21","author":"Garc\u00eda","year":"2012","journal-title":"Rev. Ecuat. Neurol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1515\/cclm-2021-0651","article-title":"Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid.","volume":"60","author":"Gobom","year":"2022","journal-title":"Clin. Chem. Lab. Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"4192","DOI":"10.3390\/ijms23084192","article-title":"Alzheimer\u2019s disease and tau self-assembly: In the search of the missing link.","volume":"23","author":"Gonz\u00e1lez","year":"","journal-title":"Int. J. Mol. Sci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13195-022-00996-8","article-title":"Glucose metabolism and AD: Evidence for a potential diabetes type 3.","volume":"14","author":"Gonz\u00e1lez","year":"","journal-title":"Alzheimers Res. Ther."},{"key":"B58","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3233\/JAD-230150","article-title":"The multifactorial etiopathogenesis of Alzheimer\u2019s disease: Neuroinflammation as the major contributor.","volume":"94","author":"Gonz\u00e1lez","year":"2023","journal-title":"J. Alzheimers Dis."},{"key":"B59","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3233\/JAD-200386","article-title":"Plasma Tau variants detected by a novel anti-tau monoclonal antibody: A potential biomarker for Alzheimer\u2019s disease.","volume":"77","author":"Gonz\u00e1lez","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"B60","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3233\/JAD-230454","article-title":"Toward prevention and reduction of Alzheimer\u2019s disease.","volume":"96","author":"Gonz\u00e1lez-Madrid","year":"2023","journal-title":"J. Alzheimers Dis."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.3233\/JAD-201501","article-title":"Interventional study to evaluate the clinical effects and safety of the nutraceutical compound BrainUp-10\u00ae in a cohort of patients with Alzheimer\u2019s disease: A multicenter, randomized, double-blind, and placebo-controlled trial.","volume":"81","author":"Guzman-Martinez","year":"","journal-title":"J. Alzheimers Dis."},{"key":"B62","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.3233\/JAD-201059","article-title":"New Frontiers in the prevention, diagnosis, and treatment of Alzheimer\u2019s disease.","volume":"82","author":"Guzman-Martinez","year":"","journal-title":"J. Alzheimers Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.3233\/JAD-180637","article-title":"The Alz-tau biomarker for Alzheimer\u2019s disease: Study in a Caucasian population.","volume":"67","author":"Guzm\u00e1n-Mart\u00ednez","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e3001694","DOI":"10.1371\/journal.pbio.3001694","article-title":"If amyloid drives Alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline?","volume":"20","author":"Haass","year":"2022","journal-title":"PLoS Biol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"31925","DOI":"10.52965\/001c.31925","article-title":"Aducanumab, a novel anti-amyloid monoclonal antibody, for the treatment of Alzheimer\u2019s disease: A comprehensive review.","volume":"10","author":"Haddad","year":"2022","journal-title":"Health Psychol. Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.3390\/brainsci13091258","article-title":"Neuroprotective potential of flavonoids in brain disorders.","volume":"13","author":"Hasan","year":"2023","journal-title":"Brain Sci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/jcbfm.2012.39","article-title":"Topology and hemodynamics of the cortical cerebrovascular system.","volume":"32","author":"Hirsch","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B68","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3233\/JAD-160867","article-title":"Meditation and music improve memory and cognitive function in adults with subjective cognitive decline: A pilot randomized controlled trial.","volume":"56","author":"Innes","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"B69","doi-asserted-by":"publisher","first-page":"492","DOI":"10.9734\/jpri\/2021\/v33i63a36091","article-title":"Development, characterization and evaluation of lactoferrin conjugated and memantine loaded Peg-Plga nanoparticles for the treatment of Alzheimer\u2019s disease.","volume":"33","author":"Jain","year":"2021","journal-title":"J. Pharm Res. Int."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3233\/JAD-191258","article-title":"Targeting mitophagy in Alzheimer\u2019s disease.","volume":"78","author":"Jayatunga","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.3233\/JAD-161141","article-title":"The gut microbiota and Alzheimer\u2019s disease.","volume":"58","author":"Jiang","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"B72","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.3390\/molecules23123229","article-title":"Molecular and functional interaction of the myokine irisin with physical exercise and Alzheimer\u2019s disease.","volume":"23","author":"Jin","year":"2018","journal-title":"Molecules"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/j.1471-4159.1989.tb07399.x","article-title":"Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease.","volume":"53","author":"Kalaria","year":"1989","journal-title":"J. Neurochem."},{"key":"B74","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S1474-4422(20)30231-3","article-title":"Brain insulin resistance in Alzheimer\u2019s disease and related disorders: Mechanisms and therapeutic approaches.","volume":"19","author":"Kellar","year":"2020","journal-title":"Lancet Neurol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e12334","DOI":"10.1002\/dad2.12334","article-title":"Alzheimer\u2019s disease diagnosis and management: Perspectives from around the world.","volume":"14","author":"Kerwin","year":"2022","journal-title":"Alzheimers Dement."},{"key":"B76","doi-asserted-by":"publisher","first-page":"e12131","DOI":"10.1002\/dad2.12131","article-title":"Concordance of CSF measures of Alzheimer\u2019s pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays.","volume":"13","author":"Keshavan","year":"2021","journal-title":"Alzheimers Dement."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-142766","article-title":"Stress, meditation, and Alzheimer\u2019s disease prevention: Where the evidence stands.","volume":"48","author":"Khalsa","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1097\/MNM.0b013e32832fa26c","article-title":"Cerebral blood flow changes during chanting meditation.","volume":"30","author":"Khalsa","year":"2009","journal-title":"Nuclear Med. Commun."},{"key":"B79","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/biom10010059","article-title":"Neuroprotective effects of quercetin in Alzheimer\u2019s disease.","volume":"10","author":"Khan","year":"2020","journal-title":"Biomolecules"},{"key":"B80","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/cns.12814","article-title":"Evaluation of cerebrospinal fluid phosphorylated tau231 as a biomarker in the differential diagnosis of Alzheimer\u2019s disease and vascular dementia.","volume":"24","author":"Ki\u0111emet-Piska\u010d","year":"2018","journal-title":"CNS Neurosci. Ther."},{"key":"B81","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1016\/j.neuron.2023.08.012","article-title":"Irisin reduces amyloid-\u03b2 by inducing the release of neprilysin from astrocytes following downregulation of ERK-STAT3 signaling.","volume":"111","author":"Kim","year":"2023","journal-title":"Neuron"},{"key":"B82","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fnmol.2014.00065","article-title":"Physiological and pathological phosphorylation of tau by Cdk5.","volume":"7","author":"Kimura","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","article-title":"Inflammation as a central mechanism in Alzheimer\u2019s disease.","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimers Dement."},{"key":"B84","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/alz.12213","article-title":"Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019.","volume":"17","author":"Knopman","year":"2021","journal-title":"Alzheimers Dement."},{"key":"B85","doi-asserted-by":"publisher","first-page":"a023721","DOI":"10.1101\/cshperspect.a023721","article-title":"Tau positron emission tomography imaging.","volume":"9","author":"Kolb","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"943","DOI":"10.17219\/acem\/171379","article-title":"Lecanemab (Leqembi) is not the right drug for patients with Alzheimer\u2019s disease.","volume":"32","author":"Kurkinen","year":"2023","journal-title":"Adv. Clin. Exp. Med."},{"key":"B87","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.fshw.2016.10.003","article-title":"Ketogenic diets and Alzheimer\u2019s disease.","volume":"6","author":"Lange","year":"2017","journal-title":"Food Sci. Hum. Wellness"},{"key":"B88","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3390\/nu13020361","article-title":"The immunopathogenesis of Alzheimer\u2019s disease is related to the composition of gut microbiota.","volume":"13","author":"Leblhuber","year":"2021","journal-title":"Nutrients"},{"key":"B89","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13024-015-0035-6","article-title":"Human neural stem cells alleviate Alzheimer-like pathology in a mouse model.","volume":"10","author":"Lee","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1139558","DOI":"10.3389\/fnut.2023.1139558","article-title":"Polyphenols: Natural food grade biomolecules for treating neurodegenerative diseases from a multi-target perspective.","volume":"10","author":"Li","year":"2023","journal-title":"Front. Nutr."},{"key":"B91","doi-asserted-by":"publisher","first-page":"370432","DOI":"10.1155\/2015\/370432","article-title":"Neural stem cell transplant-induced effect on neurogenesis and cognition in Alzheimer Tg2576 mice is inhibited by concomitant treatment with amyloid-lowering or cholinergic \u03b17 nicotinic receptor drugs.","volume":"2015","author":"Lilja","year":"2015","journal-title":"Neural Plast."},{"key":"B92","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.febslet.2007.12.035","article-title":"Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease.","volume":"582","author":"Liu","year":"2008","journal-title":"FEBS Lett."},{"key":"B93","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.3390\/ijms22062897","article-title":"Physical exercise and Alzheimer\u2019s disease: Effects on pathophysiological molecular pathways of the disease.","volume":"22","author":"L\u00f3pez-Ortiz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B94","doi-asserted-by":"publisher","first-page":"953991","DOI":"10.3389\/fncel.2022.953991","article-title":"Irisin stimulates protective signaling pathways in rat hippocampal neurons.","volume":"16","author":"Lourenco","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"B95","first-page":"58","article-title":"FNDC5\/irisin corrects memory deficits in animal models of Alzheimer\u2019s disease.","volume":"142","author":"Lourenco","year":"2017","journal-title":"J. Neurochem."},{"key":"B96","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41591-018-0275-4","article-title":"Exercise-linked FNDC5\/irisin rescues synaptic plasticity and memory defects in Alzheimer\u2019s models.","volume":"25","author":"Lourenco","year":"2019","journal-title":"Nat. Med."},{"key":"B97","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/jnc.14945","article-title":"Soluble A\u03b2 oligomers and protofibrils induce NLRP3 inflammasome activation in microglia.","volume":"155","author":"Lu\u010di\u016bnait\u0117","year":"2020","journal-title":"J. Neurochem."},{"key":"B98","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3233\/jad-2007-12410","article-title":"Earliest stages of tau conformational changes are related to the appearance of a sequence of specific phospho-dependent tau epitopes in Alzheimer\u2019s disease.","volume":"12","author":"Luna-Mu\u00f1oz","year":"2007","journal-title":"J. Alzheimers Dis."},{"key":"B99","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3390\/ijms19020461","article-title":"Evaluation of polyphenol anthocyanin-enriched extracts of blackberry, black raspberry, blueberry, cranberry, red raspberry, and strawberry for free radical scavenging, reactive carbonyl species trapping, anti-glycation, anti-\u03b2-amyloid aggregation, and microglial neuroprotective effects.","volume":"19","author":"Ma","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B100","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.arcmed.2010.03.007","article-title":"The revitalized tau hypothesis on Alzheimer\u2019s disease.","volume":"41","author":"Maccioni","year":"2010","journal-title":"Arch. Med. Res."},{"key":"B101","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.neurobiolaging.2005.01.011","article-title":"Anomalously phosphorylated tau and Abeta fragments in the CSF correlates with cognitive impairment in MCI subjects.","volume":"27","author":"Maccioni","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.3233\/JAD-191014","article-title":"Inflammation: A major target for compounds to control Alzheimer\u2019s disease.","volume":"76","author":"Maccioni","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"B103","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1749-6632.2008.03972.x","article-title":"The role of neuroimmunomodulation in Alzheimer\u2019s disease.","volume":"1153","author":"Maccioni","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B104","doi-asserted-by":"publisher","first-page":"5895","DOI":"10.3390\/ijms21165895","article-title":"Possible neuroprotective mechanisms of physical exercise in neurodegeneration.","volume":"21","author":"Mahalakshmi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B105","doi-asserted-by":"publisher","first-page":"838034","DOI":"10.3389\/fnagi.2022.838034","article-title":"Amyloid and Tau positron emission tomography imaging in Alzheimer\u2019s disease and other tauopathies.","volume":"14","author":"Maschio","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"B106","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.neurobiolaging.2016.02.034","article-title":"Clinical validity of cerebrospinal fluid A\u03b242, tau, and phospho-tau as biomarkers for Alzheimer\u2019s disease in the context of a structured 5-phase development framework.","volume":"52","author":"Mattsson","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1179807","DOI":"10.3389\/fnut.2023.1179807","article-title":"Homocysteine-a retrospective and prospective appraisal.","volume":"10","author":"McCaddon","year":"2023","journal-title":"Front. Nutr."},{"key":"B108","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3390\/brainsci11020215","article-title":"Cerebrospinal fluid biomarkers of Alzheimer\u2019s disease: Current evidence and future perspectives.","volume":"11","author":"McGrowder","year":"2021","journal-title":"Brain Sci."},{"key":"B109","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1080\/00207454.2021.1962863","article-title":"The effect of vitamin B12 on synaptic plasticity of hippocampus in Alzheimer\u2019s disease model rats.","volume":"133","author":"Mehrdad","year":"2023","journal-title":"Int. J. Neurosci."},{"key":"B110","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3389\/fnins.2020.00131","article-title":"Relationship between exercise and Alzheimer\u2019s disease: A narrative literature review.","volume":"14","author":"Meng","year":"2020","journal-title":"Front. Neurosci."},{"key":"B111","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1002\/alz.13764","article-title":"Clinical validation of the PRECIVITYAD2 blood test: A mass spectrometry-based test with algorithm combining %p-tau217 and A\u03b242\/40 ratio to identify presence of brain amyloid.","volume":"20","author":"Meyer","year":"2024","journal-title":"Alzheimers Dement."},{"key":"B112","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1753-4887.1999.tb06936.x","article-title":"Homocysteine and Alzheimer\u2019s disease.","volume":"57","author":"Miller","year":"1999","journal-title":"Nutr. Rev."},{"key":"B113","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3233\/JAD-131843","article-title":"Tau oligomers and fibrils induce activation of microglial cells.","volume":"37","author":"Morales","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"B114","doi-asserted-by":"publisher","first-page":"e0170547","DOI":"10.1371\/journal.pone.0170547","article-title":"Aerobic exercise for Alzheimer\u2019s disease: A randomized controlled pilot trial.","volume":"12","author":"Morris","year":"2017","journal-title":"PLoS One"},{"key":"B115","doi-asserted-by":"publisher","first-page":"4661","DOI":"10.3390\/ijms20194661","article-title":"The role of protein misfolding and tau oligomers (TauOs) in Alzheimer\u2019s disease (AD).","volume":"20","author":"Mroczko","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B116","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1126\/science.abn1366","article-title":"Cytosolic antibody receptor TRIM21 is required for effective tau immunotherapy in mouse models.","volume":"379","author":"Mukadam","year":"2023","journal-title":"Science"},{"key":"B117","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.sjbs.2014.05.003","article-title":"Alzheimer\u2019s disease and type 2 diabetes via chronic inflammatory mechanisms.","volume":"22","author":"Mushtaq","year":"2015","journal-title":"Saudi J. Biol. Sci."},{"key":"B118","doi-asserted-by":"publisher","first-page":"eaav9518","DOI":"10.1126\/science.aav9518","article-title":"Amyloid \u03b2 oligomers constrict human capillaries in Alzheimer\u2019s disease via signaling to pericytes.","volume":"365","author":"Nortley","year":"2019","journal-title":"Science"},{"key":"B119","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14283\/jpad.2018.45","article-title":"AADvac1, an active immunotherapy for Alzheimer\u2019s disease and non alzheimer tauopathies: An overview of preclinical and clinical development.","volume":"6","author":"Novak","year":"2019","journal-title":"J. Prev. Alzheimers Dis."},{"key":"B120","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/metabo14010025","article-title":"A potential role for the ketogenic diet in Alzheimer\u2019s disease treatment: Exploring pre-clinical and clinical evidence.","volume":"14","author":"Oliveira","year":"2024","journal-title":"Metabolites"},{"key":"B121","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jns.2009.02.367","article-title":"Effects of multisensory stimulation on cognition, depression and anxiety levels of mildly-affected Alzheimer\u2019s patients.","volume":"283","author":"Ozdemir","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"B122","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s12640-013-9398-z","article-title":"Memantine and cholinesterase inhibitors: Complementary mechanisms in the treatment of Alzheimer\u2019s disease.","volume":"24","author":"Parsons","year":"2013","journal-title":"Neurotox. Res."},{"key":"B123","volume-title":"FDA grants traditional approval for LEQEMBI<sup>\u00ae<\/sup> (lecanemab-irmb) for the treatment of Alzheimer\u2019s disease.","year":"2023"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1038\/s41591-025-03559-0","article-title":"Allogeneic mesenchymal stem cell therapy with laromestrocel in mild Alzheimer\u2019s disease: A randomized controlled phase 2a trial.","volume":"31","author":"Rash","year":"2025","journal-title":"Nat. Med."},{"key":"B125","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3390\/microorganisms8020199","article-title":"Polyphenols in Alzheimer\u2019s disease and in the gut-brain axis.","volume":"8","author":"Reddy","year":"2020","journal-title":"Microorganisms"},{"key":"B126","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3390\/life14020196","article-title":"Mitochondria in Alzheimer\u2019s disease pathogenesis.","volume":"14","author":"Reiss","year":"2024","journal-title":"Life"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.4103\/1673-5374.332127","article-title":"Amyloid-beta peptide and tau protein crosstalk in Alzheimer\u2019s disease.","volume":"17","author":"Roda","year":"2022","journal-title":"Neural Regen. Res."},{"key":"B128","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1212\/WNL.0b013e318245d295","article-title":"\u03b2-Amyloid burden in healthy aging: Regional distribution and cognitive consequences.","volume":"78","author":"Rodrigue","year":"2012","journal-title":"Neurology"},{"key":"B129","doi-asserted-by":"publisher","first-page":"756357","DOI":"10.1100\/2012\/756357","article-title":"A review: Inflammatory process in Alzheimer\u2019s disease, role of cytokines.","volume":"2012","author":"Rubio-Perez","year":"2012","journal-title":"ScientificWorldJournal"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000369101","article-title":"Amyloid-beta: A crucial factor in Alzheimer\u2019s disease.","volume":"24","author":"Sadigh-Eteghad","year":"2015","journal-title":"Med. Principles Pract."},{"key":"B131","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1093\/hmg\/ddz120","article-title":"Cdk5 increases MARK4 activity and augments pathological tau accumulation and toxicity through tau phosphorylation at Ser262.","volume":"28","author":"Saito","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"B132","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s11682-014-9329-5","article-title":"Participation in cognitively-stimulating activities is associated with brain structure and cognitive function in preclinical Alzheimer\u2019s disease.","volume":"9","author":"Schultz","year":"2015","journal-title":"Brain Imaging Behav."},{"key":"B133","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3389\/fendo.2014.00110","article-title":"Insulin as a bridge between type 2 diabetes and alzheimer disease - How anti-diabetics could be a solution for dementia.","volume":"5","author":"Sebasti\u00e3o","year":"2014","journal-title":"Front. Endocrinol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1056\/NEJMoa011613","article-title":"Plasma homocysteine as a risk factor for dementia and Alzheimer\u2019s disease.","volume":"346","author":"Seshadri","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"B135","doi-asserted-by":"publisher","first-page":"102363","DOI":"10.1016\/j.jchemneu.2023.102363","article-title":"Curcumin alleviates Alzheimer\u2019s disease by inhibiting inflammatory response, oxidative stress and activating the AMPK pathway.","volume":"134","author":"Shao","year":"2023","journal-title":"J. Chem. Neuroanat."},{"key":"B136","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12916-023-02940-5","article-title":"Association of pro-inflammatory diet with increased risk of all-cause dementia and Alzheimer\u2019s dementia: A prospective study of 166,377 UK Biobank participants.","volume":"21","author":"Shi","year":"2023","journal-title":"BMC Med."},{"key":"B137","doi-asserted-by":"publisher","first-page":"e0264557","DOI":"10.1371\/journal.pone.0264557","article-title":"Exercise-induced increase in blood-based brain-derived neurotrophic factor (BDNF) in people with multiple sclerosis: A systematic review and meta-analysis of exercise intervention trials.","volume":"17","author":"Shobeiri","year":"2022","journal-title":"PLoS One"},{"key":"B138","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12974-022-02565-0","article-title":"Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer\u2019s disease.","volume":"19","author":"Singh","year":"2022","journal-title":"J. Neuroinflamm."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.3233\/JAD-160652","article-title":"Tau platelets correlate with regional brain atrophy in patients with Alzheimer\u2019s disease.","volume":"55","author":"Slachevsky","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"B140","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s13311-022-01308-6","article-title":"Lecanemab, aducanumab, and gantenerumab - binding profiles to different forms of amyloid-beta might explain efficacy and side effects in clinical trials for Alzheimer\u2019s disease.","volume":"20","author":"S\u00f6derberg","year":"2023","journal-title":"Neurotherapeutics"},{"key":"B141","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.biopha.2016.06.021","article-title":"Pelargonidin improves memory deficit in amyloid \u03b225-35 rat model of Alzheimer\u2019s disease by inhibition of glial activation, cholinesterase, and oxidative stress.","volume":"83","author":"Sohanaki","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"B142","doi-asserted-by":"publisher","first-page":"120166","DOI":"10.1016\/j.jns.2022.120166","article-title":"Mediterranean diet adherence, gut microbiota, and Alzheimer\u2019s or Parkinson\u2019s disease risk: A systematic review.","volume":"434","author":"Solch","year":"2022","journal-title":"J. Neurol. Sci."},{"key":"B143","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/ca.980080612","article-title":"An English translation of Alzheimer\u2019s 1907 paper, \u201cUber eine eigenartige Erkankung der Hirnrinde\u201d.","volume":"8","author":"Stelzmann","year":"1995","journal-title":"Clin. Anat."},{"key":"B144","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3233\/JAD-191096","article-title":"A systematic review of the association between psychological stress and dementia risk in humans.","volume":"78","author":"Stuart","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.4103\/1673-5374.139483","article-title":"Neuroprotective effects of berry fruits on neurodegenerative diseases.","volume":"9","author":"Subash","year":"2014","journal-title":"Neural Regen. Res."},{"key":"B146","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/ibra.12098","article-title":"Basic information about memantine and its treatment of Alzheimer\u2019s disease and other clinical applications.","volume":"9","author":"Tang","year":"2023","journal-title":"Ibrain"},{"key":"B147","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3233\/JAD-170188","article-title":"The mechanisms of action of curcumin in Alzheimer\u2019s disease.","volume":"58","author":"Tang","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"B148","first-page":"663","article-title":"AN-1792 (Elan).","volume":"2","author":"Thatte","year":"2001","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"B149","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1093\/brain\/awt188","article-title":"Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer\u2019s coordinating centre.","volume":"136","author":"Toledo","year":"2013","journal-title":"Brain"},{"key":"B150","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s13311-021-01146-y","article-title":"Neuropathology of Alzheimer\u2019s disease.","volume":"19","author":"Trejo-Lopez","year":"2022","journal-title":"Neurotherapeutics"},{"key":"B151","doi-asserted-by":"publisher","first-page":"6518","DOI":"10.3390\/ijms24076518","article-title":"Inflammatory processes in Alzheimer\u2019s disease-pathomechanism, diagnosis and treatment: A review.","volume":"24","author":"Twarowski","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B152","doi-asserted-by":"publisher","first-page":"123","DOI":"10.29076\/issn.2528-7737vol10iss25.2017pp123-133p","article-title":"Influencia del estr\u00e9s en la enfermedad de Alzheimer. \/\/ Stress influence in Alzheimer\u2019s disease.","volume":"10","author":"Vallejo-Johnson","year":"2018","journal-title":"Ciencia UNEMI"},{"key":"B153","doi-asserted-by":"publisher","first-page":"668","DOI":"10.3390\/nu14030668","article-title":"The potential role of gut microbiota in Alzheimer\u2019s disease: From diagnosis to treatment.","volume":"14","author":"Varesi","year":"2022","journal-title":"Nutrients"},{"key":"B154","doi-asserted-by":"publisher","first-page":"146476","DOI":"10.1016\/j.brainres.2019.146476","article-title":"The effect of curcumin on cognition in Alzheimer\u2019s disease and healthy aging: A systematic review of pre-clinical and clinical studies.","volume":"1725","author":"Voulgaropoulou","year":"2019","journal-title":"Brain Res."},{"key":"B155","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.trci.2017.03.005","article-title":"UB-311, a novel UBITh\u00ae amyloid \u03b2 peptide vaccine for mild Alzheimer\u2019s disease.","volume":"3","author":"Wang","year":"2017","journal-title":"Alzheimers Dement."},{"key":"B156","doi-asserted-by":"publisher","first-page":"1117172","DOI":"10.3389\/fimmu.2023.1117172","article-title":"The effects of microglia-associated neuroinflammation on Alzheimer\u2019s disease.","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/WCO.0000000000001198","article-title":"Advanced brain imaging for the diagnosis of Alzheimer disease.","volume":"36","author":"Wang","year":"2023","journal-title":"Curr. Opin. Neurol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"1177424","DOI":"10.3389\/fnins.2023.1177424","article-title":"A deep learning framework for identifying Alzheimer\u2019s disease using fMRI-based brain network.","volume":"17","author":"Wang","year":"2023","journal-title":"Front. Neurosci."},{"key":"B159","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.jalz.2016.04.001","article-title":"Collaboration for Alzheimer\u2019s prevention: Principles to guide data and sample sharing in preclinical Alzheimer\u2019s disease trials.","volume":"12","author":"Weninger","year":"2016","journal-title":"Alzheimers Dement."},{"key":"B160","doi-asserted-by":"publisher","first-page":"236","DOI":"10.14283\/jpad.2017.36","article-title":"Preclinical and clinical development of ABBV-8E12, a humanized anti-tau antibody, for treatment of Alzheimer\u2019s disease and other tauopathies.","volume":"4","author":"West","year":"2017","journal-title":"J. Prev. Alzheimers Dis."},{"key":"B161","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jalz.2012.11.008","article-title":"[18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer\u2019s disease.","volume":"9","author":"Xia","year":"2013","journal-title":"Alzheimers Dement."},{"key":"B162","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/cns.13779","article-title":"Ketogenic diet ameliorates cognitive impairment and neuroinflammation in a mouse model of Alzheimer\u2019s disease.","volume":"28","author":"Xu","year":"2022","journal-title":"CNS Neurosci. Ther."},{"key":"B163","first-page":"432","article-title":"[Cognitive plasticity in Alzheimer\u2019s disease patients receiving cognitive stimulation programs].","volume":"20","author":"Zamarr\u00f3n Cassinello","year":"2008","journal-title":"Psicothema"},{"key":"B164","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.lfs.2019.03.055","article-title":"Molecular mechanisms underlying protective role of quercetin in attenuating Alzheimer\u2019s disease.","volume":"224","author":"Zaplatic","year":"2019","journal-title":"Life Sci."},{"key":"B165","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/jnc.13413","article-title":"Neural stem cell transplantation decreases neuroinflammation in a transgenic mouse model of Alzheimer\u2019s disease.","volume":"136","author":"Zhang","year":"2016","journal-title":"J. Neurochem."},{"key":"B166","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3390\/ijms21020493","article-title":"Quercetin in Animal models of Alzheimer\u2019s disease: A systematic review of preclinical studies.","volume":"21","author":"Zhang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B167","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.cell.2015.10.067","article-title":"Establishment and dysfunction of the blood-brain barrier.","volume":"163","author":"Zhao","year":"2015","journal-title":"Cell"},{"key":"B168","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40035-016-0054-4","article-title":"The dual roles of cytokines in Alzheimer\u2019s disease: Update on interleukins, TNF-\u03b1, TGF-\u03b2 and IFN-\u03b3.","volume":"5","author":"Zheng","year":"2016","journal-title":"Transl. Neurodegener."},{"key":"B169","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/sj.emboj.7600441","article-title":"A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons.","volume":"24","author":"Zheng","year":"2005","journal-title":"EMBO J."}],"container-title":["Frontiers in Cellular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fncel.2025.1655342\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:45:15Z","timestamp":1757573115000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fncel.2025.1655342\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":169,"alternative-id":["10.3389\/fncel.2025.1655342"],"URL":"https:\/\/doi.org\/10.3389\/fncel.2025.1655342","relation":{},"ISSN":["1662-5102"],"issn-type":[{"value":"1662-5102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,10]]},"article-number":"1655342"}}